Jim Cramer's Mad Money In-Depth Stock Picks, Jan. 28

Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Monday January 28. Click on a stock ticker for more analysis:

Fallen Angel: VF. Corp (VFC)

Cramer discussed "fallen angels" or stocks which deserve to trade at a higher multiple, but are down because of the market's stupidity. Cramer appaluds VFC's move in selling its "horrible" intimate apparel business which had "razor-thin margins" in order to let its more successful businesses thrive. However, investors did not hear this good news and instead paid too much attention to the company's disappointment with its fourth quarter and consequently "threw it down the pit." The stock dropped 7%, but Cramer predicts that it will miss its quarter by a mere three cents, and it should return to where it was and go higher after it reports on February 6.

Bad Press for Amgen (AMGN)

Cramer's second fallen angel, Amgen, was the victim of a negative headline which alleged that its Aranesp drug was potentially fatal when the patients who died were not expected to recover, regardless of the medicine. Low guidance was another factor in the stock's slip, but Cramer says that AMGN historically is conservative with guidance and expects to see an upside surprise. In addition, he notes that the company has drugs for osteoperosis and colon cancer in the pipeline.

Related: Centient Biotech Investor comments that Amgen brought down the biotech sector.

Oxford Blues: Quest Diagnostic (DGX), United Health (UNH)

Cramer's third fallen angel is DGX, which fell apparently on the news of its split with Oxford Health, but Cramer believes that this factor was already built into the price. Cramer would buy DGX now, since it reported a good quarter and is cheap because of its low guidance. Although DGX thinks it will lose UNH, since UNH owns Oxford, Cramer does not believe this will happen and suspects DGX of low-balling, and predicts lackluster expectations will cause the stock to soar.

CEO Interview, Peter van Stolk, Jones' Soda (JDSA)

Cramer asked Peter van Stolk if Jones' increase should continue now that its exclusive soda contract with Target has expired. While van Stolk commented that Target is a great retailer and that he expects to continue working with them, new opportunities should cause the stock to ramp. One of Jones' major selling points is that it uses pure cane sugar rather than corn syrup."Corn is for cars, and sugar is for sodas," he quipped. Since Jones has had a "monster move," Cramer would wait for it to come down a bit before buying.

Related: Clyde Milton discusses the advantages of Jones' soda with its pure cane sugar formula over corn syrup-sweetened colas.

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and his Wall Street Confidential.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com